Table GPS-2. Lifetime prevalence of drug use among young adults (aged 15 to 34 years) in nationwide surveys among the general population

Country Geographical area		Year	Reference	Age range young adults	Sample size young adults	Cannabis (%)	Cocaine (%) (1)	Amphetamines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium
Vlaanderen (Brussels excluded)		1994	(1)	18-34		9.2	1.2	2	1.3
French Community		1996–97	(2)	18-34	508	17.8
French Community		1998–99	(3)	18-34	461	26.5
French Community		2000	(4)	18-34	282	30.9
National		2001	(5)	15-34	2758	19.2		4
National		2004	(6)	15-34		23.7
Bulgaria
National		2005	(1)	18-34	433	8.7	2.4	2.8	2.6	1.5
Czech Republic
National		2002	(1)	18-34	1002	38		4.3	8.8	4.7
National		2004	(2)	18-34	1414	38.3	1.8	4.7	14.6	2.5
Denmark
National		1990	(1)	16-44		36
National		1994	(2)		2521			4
National		2000	(3)	16-34	4141	44.6	4.5	9.6	2.6	1.3
National		2005	(4)	16-34	3583	49.5	9.1	12.7	5.3	2.4
Germany
East Germany		1990	(1)	12-39		1	0.1	0.1
Western Germany		1990	(2)	12-39	19207	14.5	1.3	2.7
Old and new Länder		1995	(3)	18-34	3157	19.7	3.6	4.3	3.2
Old and new Länder		1997	(4)	18-34	3058	19.5	2.2	2.4	3.6
National		2000	(5)	18-34	3107	30.8	4	3.4	3.7	2.4
National		2003	(6)	18-34	3775	36.1	5	5.4	5.3	3.4
National		2006	(7)	18-34	3306	37.5	4.9	5.1	5.6	2.9
Estonia
National		1998	(1)	18-34	804	9	2	3	2	1
National		2003	(2)	15-34	646
Ireland
National		1998	(1)	18-34	318	26.2
National		1998	(2)	18-34		30
National		2000	(3)	18-34	404	19.7
National		2002–03	(4)	15-34		24	4.7	4.8	7.1	4.6
National		2006–07	(5)	15-34	1989	28.6	8.2	5.1	9	3.6
Greece
Athens		1993	(1)	18-35		15.5	1.5	1.7
National (except Aegean and Ionian Islands)		1998	(2)	15-34	2014	19.7	2.2	0.7	0.6
National (except Aegean and Ionian Islands)		2004	(3)	15-34	2620	10.8	1	0.2	0.6	0.4
Spain
National		1995	(1)	15-34	5813	22.9	5.9	4	3.5
National		1997	(2)	15-34	6898	31.8	5.2	4	4.7
National		1999	(3)	15-34	6293	28.5	4.8	3.2	4.4
National		2001	(4)	15-34	6915	35	7.7	4.8	7.9
National		2003	(5)	15-34	5357	39	8.9	4.7	8.3
National		2005–06	(6)	15-34	14699	38.6	9.6	5.3	7
France
National		1992	(1)	15-34	373
Metropolitan France		1995	(2)		756	27.7	1.8	1.6
National		1999	(3)	18-34	753	32.9	1.9	0.1	1.7	1.5
National		2000	(4)	15-34	4749	35.7	1.9	1.4	1.8	2
Metropolitan France		2002	(5)	15-34	724	39.9	3	0.1	1.9	1.5
National		2005	(6)	15-34	10855	43.6	3.5	1.3	3.7	1.6
Italy
National		2001	(1)	15-34	3698	24.5	4	1.4	2.6	0
National		2003	(2)	15-34	5231	29.9	6.2	2	3.3	3
National		2005	(3)	15-34	16552	34.6	7.4	2.2	3.4	3.8
Cyprus
National		2006	(1)	15-34	1753	9.9	1.4	0.8	2.4	1
Latvia
National		2003	(1)	15-34		19.6	1.9	5.3	5	2.2
Lithuania
National		2004	(1)	15-34	1814	13	0.7	2.2	2.1	0.5
Luxembourg
National		1998	(1)	15-34		15.8	0.3		1.9	1.3
Hungary
National		2001	(1)	18-34	790	13	1.3	3.6	4.5	3.1
National		2003	(2)	18-34	2319	17.4	1.5	4.5	5.6	3.1
Malta
National		2001	(1)	18-34	640	4.8	0.9	0.7	1.4	0.5
Netherlands
National		1997–98	(1)	15-34	9090	27.3	3.7	3	4.4	1.5
National		2001	(2)	15-34		29.5	2.7	3.5	6.9	1.3
National		2005	(3)	15-34		32.3	4.9	3	8.1	1.5
Austria
National		2004	(1)	15-34	1754	28	2.8	3.5	4.6	1.8
Poland
National		2002	(1)	16-34		14.7	1.3	4.1	1.5	2.5
National		2006	(2)	15-34	2031	16.1	1.3	4.8	2.1	1.6
Portugal
National		2001	(1)	15-34	6406	12.4	1.3	0.6	1.4	0.6
National		2007	(2)	15-34	4765	17	2.8	1.3	2.6	0.9
Romania
National		2004	(1)	15-34		2.9	0.7	0.5	0.5	0.3
Slovakia
National		1996	(1)	15-39	721	13.3	1.9	1.4
National		1998	(2)	15-39	665	14.4	1.8	1.4	3.7
National		2000	(3)	15-34	529	20.9	2	1.3	5.4
National		2002	(4)	15-34	548	26.9	2.2	1.7	3.9
National		2004	(5)	15-34	578	28.2	1.7	2.6	7.4
National		2006	(6)	15-34	556	28.6	2	2.4	8.4
Finland
National		1992	(1)	18-34		10.1
National		1996	(2)	16-34		15
National		1998	(3)	15-34	974	17.5	1.2	2	1.3
National		2000	(4)	15-34	615	16.6	1.2	2.5	1.4	1
National		2002	(5)	15-34	1240	22.4	1.5	4.1	3.4	1.7
National		2004	(6)	15-34	1031	22	2.1	4.1	3.3	1.4
National		2006	(7)	15-34	1387	22.1	1.7	4.7	3.6	1.2
Sweden
National		1994	(1)	16-34	310	9.1	0.3	2.9	0	0.8
National		1996	(2)	16-34	476	11.7	1.2	3.5	0.7	0
National		1998	(3)	16-34	542	15.5	0.9	2.6	0.5
National		2000	(4)	16-34	575	13.8	0.8	2.1	0.6	0
National		2004	(5)	18-34	2985	21
National		2005	(6)	16-34	9522	17.9
National		2006	(7)	16-34	14408	19.1
United Kingdom
England and Wales		1994	(1)	16-34	4329	31.6	3.4	12.4	4.7	7.4
England and Wales		1996	(2)	16-34	4720	34.5	4.4	14.5	7.5	8.9
England and Wales		1998	(3)	16-34	4112	39.5	5.8	17.2	8.2	9.1
England and Wales		2000	(4)	16-34	4910	43	9.8	20.3	11.2	10.5
England and Wales		2001–02	(5)	16-34	9006	42.2	8.7	18	11.8	8.3
England and Wales		2002–03	(6)	16-34	9826	43.4	10	18.6	13	9.1
England and Wales		2003–04	(7)	16-34	10922	43.4	11.6	18.4	13.6	9.2
England and Wales		2004–05	(8)	16-34	12630	41.4	10.5	16.5	12.7	7.3
England and Wales		2005–06	(9)	16-34	12329	41.5	12.1	16.8	13.3	7.6
England and Wales		2006–07	(10)	16-34	11973	41.4	12.7	16.5	13	7.1
Northern Ireland		2002–03	(11)	15-34		25.1	2.9	7.2	11.4	7.8
Northern Ireland		2005	(12)	16-34		28.8	6.8	11.5	12.4	5.4
Scotland		2003	(13)	16-34	1193	35.9	8.7	16.5	12.5	7.8
Scotland		2004	(14)	16-34	978	34.4	8.1	14.4	11.4	7.9
Scotland		2006	(15)	16-34	1115	49.6	15.5	22.1	19.4	11.6
United Kingdom		2004	(16)	16-34		42.3	11.1	17.9	13.4	9
Norway
National		1999	(1)	15-34	794	20.9	3.3	5.4	2.5
National		2004	(2)	15-34	1238	25.5	4.3	5.9	3.6	1.7

Notes:

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs. 

 (3) For Spain: ecstasy and other designer drugs. 

 (4) In the Netherlands, the figures for 2001 have been recomputed using only the interviews conducted with CAPI method (Computer Assisted Personal Interview) and excluding other methods of data collection (mail, telephone, etc.) to ensure comparability with 1997 and 2005. For 2005, only respondents with information collected through the CAPI method were included (this note applies to all tables and graphics regarding population surveys for the Netherlands 2001 and 2005). 

 This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey. 

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 

 For methods and definitions on population surveys in general, see General population surveys of drug use – <a href="https://www.emcdda.europa.eu/stats08/gps/methods">methods and definitions</a>. 

 For methods of each survey presented in this table, see <a href="https://www.emcdda.europa.eu/stats08/gpstab1b">Table GPS-1 part (ii)</a>.  

 See also 'General notes for interpreting data' on the <a href="https://www.emcdda.europa.eu/stats08/help">Explanatory notes and help page</a>. 

Sources:

 See <a href="https://www.emcdda.europa.eu/stats08/gpstab0">Table GPS-0</a>.  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)